Healthcare and Medical

home | healthcare and medical | company profile | table of contents

£73.00
Alerts
Change Currency EuroUSDGBP

Cadence Pharmaceuticals, Inc. - Financial and Strategic Analysis Review (Global Markets Direct)

  • Market: Healthcare and Medical
  • Published Date: 13/06/2009
  • Report Title: Cadence Pharmaceuticals, Inc. - Financial and Strategic Analysis Review
  • View Report Summary: View Report Summary
  • Report Type: Company Profile
  • Country: Global
  • Number of Pages: 14

Table Of Contents
Table Of Contents 2
List of Tables 3
List of Figures 3
Key Facts 4
Business Description 4
Major Products and Services 5
History 5
SWOT Analysis 6
SWOT Analysis - Overview 6
Cadence Pharmaceuticals, Inc. - Strengths 6
Cadence Pharmaceuticals, Inc. - Strengths - Focused on Market for Injectable Analgesics 6
Cadence Pharmaceuticals, Inc. - Strengths - Lead Product Candidate-Acetavance 6
Cadence Pharmaceuticals, Inc. - Weaknesses 6
Cadence Pharmaceuticals, Inc. - Weaknesses - Failure of Clinical Trials for Omigard 6
Cadence Pharmaceuticals, Inc. - Weaknesses - Lack of Patent Protection for Active Ingredients 6
Cadence Pharmaceuticals, Inc. - Weaknesses - History of Operating Losses 6
Cadence Pharmaceuticals, Inc. - Opportunities 6
Cadence Pharmaceuticals, Inc. - Opportunities - The Growing Hospital Use Drug Market 6
Cadence Pharmaceuticals, Inc. - Opportunities - Rising Healthcare Expenditure in the US 7
Cadence Pharmaceuticals, Inc. - Opportunities - Changing Demographics 7
Cadence Pharmaceuticals, Inc. - Threats 7
Cadence Pharmaceuticals, Inc. - Threats - Increasing Competition 7
Cadence Pharmaceuticals, Inc. - Threats - Dependence on Licensing Agreements 7
Cadence Pharmaceuticals, Inc. - Threats - Reliance on the Third Party Manufacturers 7
Key Competitors 8
Key Employees 8
Key Employee Biographies 9
Locations And Subsidiaries 9
Locations And Subsidiaries - Head Office 9
Financial Ratios 10
Financial Ratios - Capital Market Ratios 10
Financial Ratios - Annual Ratios 10
Financial Ratios - Interim Ratios 10
Financial Ratios - Ratio Charts 11
Appendix 12
Methodology 12
Ratio Definitions 12
About Global Markets Direct 15
Contact Us 15
Disclaimer 15


List of Tables
Cadence Pharmaceuticals, Inc., Key Facts 4
Major Products and Services 5
Cadence Pharmaceuticals, Inc., History 5
Cadence Pharmaceuticals, Inc., Key Employees 8
Cadence Pharmaceuticals, Inc., Key Employee Biographies 9
Cadence Pharmaceuticals, Inc., Ratios based on current share price 10
Cadence Pharmaceuticals, Inc., Annual Ratios 10
Cadence Pharmaceuticals, Inc., Interim Ratios 10
Currency Codes 12
Capital Market Ratios 12
Equity Ratios 13
Profitability Ratios 13
Cost Ratios 13
Liquidity Ratios 14
Leverage Ratios 14
Efficiency Ratios 14


List of Figures
Cadence Pharmaceuticals, Inc., Ratio Charts 11

Back to Report

£73.00   Share Report
 
Alerts  

Purchase Information

There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses Worldpay. Worldpay is part of The Royal Bank of Scotland Group, the 5th biggest banking group in the world. Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.

Worldpay Logo
Chancy Currency EUR USD GBP
Customer Area
English Italian Spanish French German Russian Chinese Arabic